Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Swann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Geriatric Psychiatry|November 18, 2003
Language impairment in dementia: impact on symptoms and care needs in residential homesDawn Potkins, Pat Myint, Carol Bannister, et al.
Chronic Stress (Thousand Oaks, Calif.)|March 28, 2022
A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in SuicidalityGuillermo Poblete, Tien Nguyen, Savannah Gosnell, et al.
The Journal of Clinical Psychiatry|January 28, 2004
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcomeClive G Ballard, Alan Thomas, Jane Fossey, et al.
The American Journal on Addictions|May 11, 2025
The association between cannabis use and suicidal intensity in psychiatric inpatientsAdeolu Funso Oladunjoye, Alan Swann, Thomas R Kosten, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 26, 2003
The social brain: a unifying foundation for psychiatryCornelis Bakker, Russell Gardner, Vassilis Koliatsos, et al.
International Journal of Geriatric Psychiatry|January 29, 2002
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilitiesClive Ballard, Ian Powell, Ian James, et al.
Biological Psychiatry|March 6, 2025
Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled TrialAvijit Chowdhury, Sarah Boukezzi, Sara Costi, et al.
BMJ (Clinical Research Ed.)|February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialClive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Research Square|September 26, 2025
A Randomized, Controlled Trial of the Novel, Potent Kv7 Channel Opener Azetukalner in Individuals with Major Depressive Disorder and Anhedonia: Neural Response to Reward, Clinical Outcomes, and SafetyJames Murrough, Rachel Fremont, Philipp Neukam, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program CohortPeter B Barr, Tim B Bigdeli, Jacquelyn L Meyers, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Geriatric Psychiatry|November 18, 2003
Language impairment in dementia: impact on symptoms and care needs in residential homesDawn Potkins, Pat Myint, Carol Bannister, et al.
Chronic Stress (Thousand Oaks, Calif.)|March 28, 2022
A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in SuicidalityGuillermo Poblete, Tien Nguyen, Savannah Gosnell, et al.
The Journal of Clinical Psychiatry|January 28, 2004
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcomeClive G Ballard, Alan Thomas, Jane Fossey, et al.
The American Journal on Addictions|May 11, 2025
The association between cannabis use and suicidal intensity in psychiatric inpatientsAdeolu Funso Oladunjoye, Alan Swann, Thomas R Kosten, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 26, 2003
The social brain: a unifying foundation for psychiatryCornelis Bakker, Russell Gardner, Vassilis Koliatsos, et al.
International Journal of Geriatric Psychiatry|January 29, 2002
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilitiesClive Ballard, Ian Powell, Ian James, et al.
Biological Psychiatry|March 6, 2025
Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled TrialAvijit Chowdhury, Sarah Boukezzi, Sara Costi, et al.
BMJ (Clinical Research Ed.)|February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialClive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Research Square|September 26, 2025
A Randomized, Controlled Trial of the Novel, Potent Kv7 Channel Opener Azetukalner in Individuals with Major Depressive Disorder and Anhedonia: Neural Response to Reward, Clinical Outcomes, and SafetyJames Murrough, Rachel Fremont, Philipp Neukam, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program CohortPeter B Barr, Tim B Bigdeli, Jacquelyn L Meyers, et al.
Pageof 2